JP2022530985A5 - - Google Patents

Info

Publication number
JP2022530985A5
JP2022530985A5 JP2021564826A JP2021564826A JP2022530985A5 JP 2022530985 A5 JP2022530985 A5 JP 2022530985A5 JP 2021564826 A JP2021564826 A JP 2021564826A JP 2021564826 A JP2021564826 A JP 2021564826A JP 2022530985 A5 JP2022530985 A5 JP 2022530985A5
Authority
JP
Japan
Prior art keywords
methylene
succinate
oxy
oxobutanoyl
methylene succinate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2021564826A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022530985A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2020/051060 external-priority patent/WO2020222011A1/en
Publication of JP2022530985A publication Critical patent/JP2022530985A/ja
Publication of JP2022530985A5 publication Critical patent/JP2022530985A5/ja
Ceased legal-status Critical Current

Links

JP2021564826A 2019-04-30 2020-04-30 炎症性疾患または望ましくない免疫応答に関連する疾患の治療におけるイタコン酸誘導体およびその使用 Ceased JP2022530985A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
EP19172051 2019-04-30
EP19172051.5 2019-04-30
EP19189910 2019-08-02
EP19189910.3 2019-08-02
EP19217846 2019-12-19
EP19217846.5 2019-12-19
EP20162494.7 2020-03-11
EP20162494 2020-03-11
PCT/GB2020/051060 WO2020222011A1 (en) 2019-04-30 2020-04-30 Itaconic acid derivatives and uses thereof in treating an inflammatory disease or a disease associated with an undesirable immune response

Publications (2)

Publication Number Publication Date
JP2022530985A JP2022530985A (ja) 2022-07-05
JP2022530985A5 true JP2022530985A5 (https=) 2023-03-27

Family

ID=70480305

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021564826A Ceased JP2022530985A (ja) 2019-04-30 2020-04-30 炎症性疾患または望ましくない免疫応答に関連する疾患の治療におけるイタコン酸誘導体およびその使用

Country Status (19)

Country Link
US (1) US12390437B2 (https=)
EP (2) EP3962602B1 (https=)
JP (1) JP2022530985A (https=)
KR (1) KR20220002952A (https=)
CN (1) CN113825740A (https=)
AU (1) AU2020264773A1 (https=)
BR (1) BR112021021301A2 (https=)
CA (1) CA3135991A1 (https=)
CO (1) CO2021015538A2 (https=)
CR (1) CR20210578A (https=)
DO (1) DOP2021000219A (https=)
EC (1) ECSP21086530A (https=)
IL (1) IL287444B2 (https=)
JO (3) JOP20210291A1 (https=)
MA (2) MA55796A (https=)
MX (1) MX2021013299A (https=)
PE (1) PE20220762A1 (https=)
SG (1) SG11202110624YA (https=)
WO (2) WO2020222010A1 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SMT202400306T1 (it) 2018-03-30 2024-09-16 Incyte Corp Trattamento dell'idrosadenite suppurativa utilizzando inibitori di jak.
HUE065501T2 (hu) 2018-08-20 2024-05-28 Janssen Pharmaceutica Nv A KEAP1-NRF2 protein-protein kölcsönhatás inhibitorok
WO2020232247A1 (en) 2019-05-14 2020-11-19 Provention Bio, Inc. Methods and compositions for preventing type 1 diabetes
PE20230405A1 (es) * 2019-10-29 2023-03-07 Univ Johns Hopkins Profarmacos de itaconato e itaconato de metilo desarrollo o investigacion patrocinados por el gobierno
BR112022008310A2 (pt) 2019-10-29 2022-08-09 Univ Johns Hopkins Uso de itaconato e seus derivados/análogos para induzir crescimento capilar
IL298999A (en) 2020-06-11 2023-02-01 Provention Bio Inc Methods and compositions for the prevention of type 1 diabetes
EP4192821A1 (en) 2020-08-05 2023-06-14 Sitryx Therapeutics Limited Alpha,beta unsaturated methacrylic esters with anti-inflammatory properties
EP4237404A1 (en) * 2020-10-29 2023-09-06 Sitryx Therapeutics Limited Novel compounds
CN114681450A (zh) * 2020-12-28 2022-07-01 苏州澳宗生物科技有限公司 依达拉奉、衍生物、药学上可接受的盐、前药或多晶型物的新用途
CN112812052B (zh) * 2021-02-02 2023-12-01 成都阿奇生物医药科技有限公司 一种治疗溃疡性结肠炎的化合物及其制备方法和用途
WO2022223778A1 (en) * 2021-04-23 2022-10-27 Helmholtz-Zentrum für Infektionsforschung GmbH Citraconic acid and derivatives thereof for use as a medicament
EP4330231A1 (en) 2021-04-26 2024-03-06 Sitryx Therapeutics Limited 2-methylene-4-oxo-butanoic acid drivatives for the treatment of inflammation
JP2024520444A (ja) 2021-05-24 2024-05-24 プロヴェンション・バイオ・インコーポレイテッド １型糖尿病を治療するための方法
EP4359390A1 (en) 2021-06-22 2024-05-01 Sitryx Therapeutics Limited Acrylamide derivatives useful as anti-inflammatory agents
US20240360067A1 (en) 2021-08-11 2024-10-31 Sitryx Therapeutics Limited Derivatives of itaconic acid and their use as anti-inflammatory agents
GB202203755D0 (en) * 2022-03-17 2022-05-04 Imperial College Innovations Ltd Treatment or prevention of respiratory diseases characterised by, or involving, lung fibrosis
CN114557993B (zh) * 2022-03-22 2023-05-12 中南大学湘雅三医院 4-衣康酸辛酯在制备胰腺提取胰岛前的注射制剂中的应用
CN115969790B (zh) * 2022-05-27 2024-09-06 哈尔滨医科大学 一种肺炎治疗药物pfc@4-oi及其制备方法与应用
CN116139117A (zh) * 2022-05-31 2023-05-23 西南医科大学附属医院 衣康酸及其衍生物在防治阿霉素诱导的心脏毒性中的应用
AU2023287566A1 (en) 2022-06-22 2025-01-16 Sitryx Therapeutics Limited Oxadiazole derivatives, preparation process thereof and their use in treating inflammatory diseases
CN115518060A (zh) * 2022-09-30 2022-12-27 中国人民解放军空军军医大学 衣康酸及其衍生物在治疗白癜风药物上的应用及其治疗白癜风的药物
WO2024089421A1 (en) 2022-10-25 2024-05-02 Sitryx Therapeutics Limited Tetrazole derivatives
CN120712258A (zh) 2022-12-15 2025-09-26 西特瑞治疗有限公司 用于治疗或预防炎性疾病或与不良免疫反应相关的疾病的取代吡啶类化合物
CN116019975A (zh) * 2023-01-06 2023-04-28 天津市天津医院 一种负载抗炎因子4-辛基衣康酸可注射水凝胶及其制备方法和应用
CN117205194A (zh) * 2023-05-10 2023-12-12 苏州大学 衣康酸或其衍生物在制备预防或治疗急性移植物抗宿主病药物中的应用
CN117530944A (zh) * 2023-12-25 2024-02-09 中国医学科学院放射医学研究所 衣康酸四辛酯在制备防治放射性肠损伤药物中的应用
CN117599037A (zh) * 2023-12-25 2024-02-27 中国医学科学院放射医学研究所 衣康酸四辛酯在制备防治辐射诱导骨髓抑制药物中的应用
WO2025153532A1 (en) 2024-01-16 2025-07-24 NodThera Limited Nlrp3 inhibitors and glp-1 agonists combination therapies
WO2026008955A1 (en) * 2024-07-03 2026-01-08 Cambridge Enterprise Limited Treatment or prevention of central nervous system (cns) disorder

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743657A (en) * 1986-03-17 1988-05-10 Milliken Research Corporation Method for preparing polymer bound stabilizers made from non-homopolymerizable stabilizers
US5422349A (en) * 1992-08-14 1995-06-06 G. D. Seale & Co. Morpholino-oxazinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
KR100538968B1 (ko) * 1997-02-18 2006-07-11 후지 샤신 필름 가부시기가이샤 포지티브감광성조성물
US6235787B1 (en) * 1997-06-30 2001-05-22 Hoffmann-La Roche Inc. Hydrazine derivatives
JP2001354625A (ja) * 2000-04-12 2001-12-25 Dainippon Ink & Chem Inc 新規なイタコン酸エステル及びその製造方法
JP4102014B2 (ja) * 2000-10-03 2008-06-18 富士フイルム株式会社 感光性平版印刷版
US6777155B2 (en) * 2000-10-03 2004-08-17 Fuji Photo Film Co., Ltd. Photosensitive lithographic printing plate
JP3925288B2 (ja) * 2002-04-22 2007-06-06 チッソ株式会社 イタコン酸誘導体およびその重合体
JP4133376B2 (ja) * 2002-09-03 2008-08-13 信越化学工業株式会社 高分子化合物及びポジ型レジスト材料並びにこれを用いたパターン形成方法
JP2004315791A (ja) * 2003-03-28 2004-11-11 Tokyo Ohka Kogyo Co Ltd ジカルボン酸モノエステル化合物およびその製造方法ならびに重合体
JP2007086285A (ja) * 2005-09-21 2007-04-05 Fujifilm Corp レジスト組成物及びそれを用いたパターン形成方法
EP2145920A1 (en) 2008-07-15 2010-01-20 Lanxess Deutschland GmbH Vulcanizable polymer compositions
EP2373617B1 (de) 2008-12-04 2015-02-25 Basf Se Mischungen aus itaconsäure oder itaconsäurederivaten und primären aminen zur herstellung von 1,3- und 1,4-alkylmethylpyrrolidonen
JP5526693B2 (ja) * 2009-10-09 2014-06-18 日油株式会社 感光性樹脂組成物およびその用途
EP2423178A1 (en) 2010-07-28 2012-02-29 Chemo Ibérica, S.A. Process for the production of sitagliptin
JP5732306B2 (ja) * 2011-04-20 2015-06-10 東京応化工業株式会社 化合物、高分子化合物、酸発生剤、レジスト組成物、レジストパターン形成方法
KR102085557B1 (ko) 2013-03-14 2020-03-06 엘커메스 파마 아일랜드 리미티드 푸마레이트의 프로드럭 및 다양한 질환을 치료하는데 있어서의 이들의 용도
EP3416634A4 (en) 2016-02-15 2019-10-09 Artyomov, Maxim IMMUNOMODULATORY AGENTS AND METHOD FOR USE THEREOF
US10047100B2 (en) 2016-04-08 2018-08-14 Regents Of The University Of Minnesota Compounds from renewable resources
WO2019036509A1 (en) * 2017-08-14 2019-02-21 Washington University METHODS AND COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH CANCER, INFLAMMATION OR IMMUNE RESPONSE
WO2019064827A1 (ja) * 2017-09-26 2019-04-04 Jnc株式会社 重合性極性化合物、液晶組成物および液晶表示素子
US12060310B2 (en) 2018-06-29 2024-08-13 Ergon Pharmaceuticals Llc Compositions and methods of using itaconic acid derivatives
CN110731955B (zh) 2019-10-28 2023-05-02 中山大学 衣康酸二甲酯在预防和治疗溃疡性结肠炎及其癌变中的应用
MX2022007846A (es) 2019-12-23 2022-07-19 Sitryx Therapeutics Ltd Derivados carboxi con propiedades antiinflamatorias.

Similar Documents

Publication Publication Date Title
JP2022530985A5 (https=)
JP2023508142A5 (https=)
HRP20241378T1 (hr) Karboksi derivati s protuupalnim svojstvima
US12390437B2 (en) Itaconic acid derivatives and uses thereof intreating an inflammatory disease or a disease associated with an undesirable immune response
AU2022270115B2 (en) Cycloalkyl 3-oxopiperazine carboxamides and cycloheteroalkyl 3-oxopiperazine carboxamides as nav1.8 inhibitors
KR102668548B1 (ko) 의학적 질병의 치료를 위한 아릴, 헤테로아릴, 및 헤테로사이클릭 화합물
US20080182845A1 (en) Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection
TW201718553A (zh) 用於治療醫學病症之醚化合物
TW201718611A (zh) 用於治療醫學病症之膦酸酯化合物
TW201718551A (zh) 用於治療醫學病症之醯胺化合物
RU2014125220A (ru) Белки, связывающие интерлейкин-1
WO2017035351A1 (en) Amino compounds for treatment of medical disorders
CN112839945A (zh) 补体因子d抑制剂的形态形式
PT2642999T (pt) Métodos de tratamento que utilizam inibidores seletivos de bcl-2
US20160175316A1 (en) Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection
CN109476705A (zh) 新型环孢菌素衍生物及其用途
CN101969951A (zh) 治疗关节炎的方法
CN113795249A (zh) 用于治疗补体介导的病症的药物化合物
WO2022229617A1 (en) 2-methylene-4-oxo-butanoic acid drivatives for the treatment of inflammation
TW201348198A (zh) 作爲ａｌｘ受體激動劑之經氟化橋聯之螺［２．４］庚烷衍生物
EP4634167A1 (en) Substituted pyridines for use in treating or preventing inflammatory diseases or diseases associated with an undesirable immune response
TW202136195A (zh) 新穎之化合物
HK40087874A (zh) 膦酰胺核苷酸类似物的前药及其药物用途
JP2026500504A (ja) Ｓ１ｐ５モジュレーターとしてのヘテロ環化合物
CN118510502A (zh) Akt3调节剂